Policy action is critical as Canada recognizes FASD Awareness Month
Advocates, medical experts, and those with lived experiences have for decades been calling on the federal government to take a leadership role.
Biotech
The prescription for Canada’s health care future
Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
Biotechnology momentum in Canada needs infusion of talent and anchor firms, say industry reps
Canada has several prominent life science firms, but none can be considered an anchor company, according to a report by the adMare Institute released in late 2023.
Senate aims to serve up pharmacare for Thanksgiving
The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote on Oct. 10.
Focus on pharmacare
Plus, Marc Miller announces new measures for temporary residents.
Canada needs to catch up in the biotech sector
Currently, our scientists have to look outside of the country to take their work to the next level, which means that Canada is not benefitting fully from Canadian ideas.
Unlocking Canada’s greatest economic potential: life sciences
The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can help solve some of our biggest societal challenges.
Canada’s biotech carpe diem
It’s imperative Canada keep pace with other competing jurisdictions, and establish itself as a regulatory leader that rewards investment and talent.
Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West
Government investment and policy can help ensure groundbreaking technologies remain in Canada when companies scale up their production especially for international distribution.
